Abe Chikara, Nishimura Saki, Mori Airi, Niimi Yuki, Yang Yi, Hane Masaya, Kitajima Ken, Sato Chihiro
Bioscience and Biotechnology Center, Nagoya University, Nagoya 464-8601, Japan.
Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan.
Int J Mol Sci. 2017 May 24;18(6):1123. doi: 10.3390/ijms18061123.
The neural cell adhesion molecule (NCAM) is modified by polysialic acid (polySia or PSA) in embryonic brains. In adult brains, polySia modification of NCAM is only observed in restricted areas where neural plasticity, remodeling of neural connections, or neural generation is ongoing although the amount of NCAM remains unchanged. Impairments of the polySia-expression and several single nucleotide polymorphisms (SNPs) of the polysialyltransferase (polyST) ST8SIA2 gene are reported to be associated with schizophrenia and bipolar disorder. Chlorpromazine (CPZ) is well-known as an agent for treating schizophrenia, and our hypothesis is that CPZ may affect the polySia expression or the gene expression of polySTs or NCAM. To test this hypothesis, we analyzed the effects of CPZ on the expression of polySia-NCAM on human neuroblastoma cell line, IMR-32 cells, by immunochemical and chemical methods. Interestingly, the cell surface expression of polySia, especially those with lower chain lengths, was significantly increased on the CPZ-treated cells, while mRNAs for polySTs and NCAM, and the amounts of total polySia-NCAM remained unchanged. The addition of brefeldin A, an inhibitor of endocytosis, suppressed the CPZ-induced cell surface polySia expression. In addition, polySia-NCAM was also observed in the vesicle compartment inside the cell. All these data suggest that the level of cell surface expression of polySia in IMR-32 is highly regulated and that CPZ changes the rate of the recycling of polySia-NCAM, leading to the up-regulation of polySia-NCAM on the cell surface. We also analyzed the effect of CPZ on polySia-expression in various brain regions in adult mice and found that CPZ only influenced the total amounts of polySia-NCAM in prefrontal cortex. These results suggest a brain-region-specific effect of CPZ on the expression of total polySia in mouse brain. Collectively, anti-schizophrenia agent CPZ consistently up-regulates the expression polySia at both cellular and animal levels.
神经细胞黏附分子(NCAM)在胚胎大脑中会被多唾液酸(polySia或PSA)修饰。在成人大脑中,尽管NCAM的总量保持不变,但只有在神经可塑性、神经连接重塑或神经生成正在进行的特定区域才能观察到NCAM的多唾液酸修饰。据报道,多唾液酸表达受损以及多唾液酸转移酶(polyST)ST8SIA2基因的几个单核苷酸多态性(SNP)与精神分裂症和双相情感障碍有关。氯丙嗪(CPZ)是一种众所周知的治疗精神分裂症的药物,我们的假设是CPZ可能会影响多唾液酸的表达或多唾液酸转移酶或NCAM的基因表达。为了验证这一假设,我们通过免疫化学和化学方法分析了CPZ对人神经母细胞瘤细胞系IMR-32细胞上多唾液酸-NCAM表达的影响。有趣的是,在CPZ处理的细胞上,多唾液酸的细胞表面表达,尤其是那些链长较短的多唾液酸,显著增加,而多唾液酸转移酶和NCAM的mRNA以及多唾液酸-NCAM的总量保持不变。添加布雷菲德菌素A(一种内吞作用抑制剂)可抑制CPZ诱导的细胞表面多唾液酸表达。此外,在细胞内的囊泡区室中也观察到了多唾液酸-NCAM。所有这些数据表明,IMR-32细胞中多唾液酸的细胞表面表达水平受到高度调节,CPZ改变了多唾液酸-NCAM的循环速率,导致细胞表面多唾液酸-NCAM上调。我们还分析了CPZ对成年小鼠不同脑区多唾液酸表达的影响,发现CPZ仅影响前额叶皮质中多唾液酸-NCAM的总量。这些结果表明CPZ对小鼠大脑中多唾液酸总表达具有脑区特异性影响。总的来说,抗精神分裂症药物CPZ在细胞和动物水平上均持续上调多唾液酸的表达。